Robotic surgery kidney risk: two drugs face off in new trial
NCT ID NCT06408597
First seen Jan 12, 2026 · Last updated May 19, 2026 · Updated 18 times
Summary
This study compares two drugs, mannitol and nitroglycerin, given during robotic surgery for prostate or bladder cancer to see if they can prevent acute kidney injury. The trial involves 90 adults with normal or mildly reduced kidney function. Researchers aim to find which drug better protects kidney health during the stress of surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cairo University Hospitals
Cairo, Egypt
Conditions
Explore the condition pages connected to this study.